Evaluation of Performance and Occlusal Wear of Low Shrinkage Giomer Compared to Nanohybrid Resin Composite

July 14, 2023 updated by: Omar Osama Shaalan, Cairo University

Evaluation of Performance and Occlusal Wear of Low Shrinkage Giomer Compared to Nanohybrid Resin Composite in Proximal Restorations After Two Years: A Randomized Clinical Trial.

A clinical trial, comparing the clinical performance and occlusal wear resistance of two different restorative materials in restoring proximal caries in permanent posterior teeth. One is based on giomer technology and the other is nano-hybrid resin composite.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

The aim of this study is to assess clinical performance and occlusal wear resistance of low shrinkage Giomer and Nanohybrid Resin Composite in proximal restorations using revised FDI (World Dental Federation) criteria and digital intra-oral scanner.

Two different restorative materials will be evaluated after two years for fracture, retention and occlusal wear. Furthermore, the rest of the revised FDI Criteria including functional (marginal adaptation, proximal contact point, form and contour, occlusion and occlusal wear) , biological (caries at restoration margin (CAR), dental hard tissue defects at restoration margin and postoperative hypersensitivity/pulp status) and esthetic properties (surface luster and surface texture, marginal staining and color match) will be also evaluated.

The first material is based on the giomer technology which is a true hybrid between nano-hybrid resin composite and glass ionomer. The comparator will be a nano-hybrid resin composite.

Examination and selection of all patients will be done. Teeth with proximal, primary carious lesions will be selected. Rubber dam isolation will be done followed by preparation of Class II cavities and placement of restorative material according to the randomization sequence.

Low-shrinkage bioactive material will be applied according to the manufacturer's instructions. For the comparator group, nano-hybrid resin composite will be also applied according to the manufacturer's instructions. Restorations will evaluated at baseline, after six, 12, 18 and 24 months.

Study Type

Interventional

Enrollment (Estimated)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Inclusion criteria for patients

    • Patient's age ranging from 19-30
    • Good oral hygiene.
    • Patients who have stable occlusion.
    • Patients who could be present for further periodic follow-ups.
    • Possibility for application of rubber dam during restoration.
    • Patient compliance.
  • Inclusion criteria for Teeth

    • Vital first and second molars, with compound Class II lesions.
    • The selected teeth should be in occlusion with natural dentition and having proximal contact with adjacent teeth.
    • Healthy periodontium.

Exclusion Criteria:

  • Exclusion criteria for patients

    • Poor oral hygiene.
    • Patients with high caries index or high plaque index.
    • Patients with periodontal problems.
    • Heavy bruxism habit or presence of any parafunctional habits.
    • Any allergic reactions against any components of the materials to be used in the study.
    • History of severe medical complications such as xerostomia.
    • Pregnant or lactating women.
    • Participating in another clinical trial.
  • Exclusion criteria for teeth

    • Fractured or evidently cracked teeth.
    • Defective restorations adjacent or opposite the selected tooth for research.
    • Atypical extrinsic staining of teeth.
    • Teeth with defects or lesions requiring other operative interventions.
    • Teeth with pulpal pain.
    • Teeth with periapical lesions.
    • Root Canal treated teeth.
    • Mobile Teeth.
    • Non-functioning teeth with no opposing tooth.
    • Signs of severe attrition.
    • Heavy occlusion.
    • Periodontally affected teeth.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low shrinkage giomer.
Low-shrinkage bioactive material (giomer) will be applied according to the manufacturer's instructions. Centripetal technique will be performed to restore the proximal wall followed by oblique incrementation of approximately 2 mm thick composite resin. This will be followed by light curing of each increment for 40 seconds using light curing unit till the whole cavity is filled.
low shrinkage bioactive material Giomer
Other Names:
  • low shrinkage Giomer
Active Comparator: Nano-hybrid resin composite
Nano-hybrid resin composite will be applied according to the manufacturer's instructions. Centripetal technique will be performed to restore the proximal wall followed by oblique incrementation of approximately 2 mm thick composite resin. Composite increments will be adapted obliquely on each cusp. This will be followed by light curing for 40 seconds using light curing unit of each increment till the whole cavity is filled.
Universal Nano-hybrid composite
Other Names:
  • Nano-hybrid composite

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional properties (F1) Fracture of material and retention according to revised FDI (World Dental Federation) criteria. Measured by visual examination and short air drying.
Time Frame: 24 months
Method of aggregation is frequency and percentage. Measuring unit is scoring system (Ordinal, scores 1-5). (1) Clinically excellent. (sufficient). (5) Clinically poor (entirely insufficient).
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quantitative occlusal restoration wear by Digital Intra-oral scanner and Geometrical subtraction software.
Time Frame: 24 months.
Method of aggregation is Mean (SD) (parametric) or Median (Range) (Non-parametric). Measuring unit is Microns.
24 months.
Functional properties according to revised FDI (World Dental Federation) criteria.
Time Frame: 24 months.

Functional properties:

F2: Marginal adaptation measured by visual examination, short air drying, 250 μm probe.

F3:Proximal contact point measured by visual examination and 25/50/100 μm blades.

F4: Form and contour measured by visual examination. F5: Occlusion and occlusal wear measured by visual examination and articulation paper.

Method of aggregation is frequency and percentage. Measuring unit is scoring system (Ordinal, scores 1-5). (1) Clinically excellent. (sufficient). (5) Clinically poor (entirely insufficient).

24 months.
Biological properties according to revised FDI criteria.
Time Frame: 24 months.

Biological properties:

B1: Caries at restoration margin (CAR) measured by visual examination, short air drying, and 250 μm probe.

B2: Dental hard tissue defects at restoration margin measured by visual examination.

B3: Postoperative hypersensitivity reported by patient and pulp status tested with cold stimulus.

Method of aggregation is frequency and percentage. Measuring unit is scoring system (Ordinal, scores 1-5). (1) Clinically excellent. (sufficient). (5) Clinically poor (entirely insufficient).

24 months.
Aesthetic properties according to revised FDI criteria.
Time Frame: 24 months.

Aesthetic properties:

A1: Surface luster and surface texture measured by visual examination and short air drying.

A2: Marginal staining measured by visual examination and short air drying. A3: color match measured by visual examination. Method of aggregation is frequency and percentage. Measuring unit is scoring system (Ordinal, scores 1-5). (1) Clinically excellent. (sufficient). (5) Clinically poor (entirely insufficient).

24 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2023

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

June 24, 2023

First Submitted That Met QC Criteria

July 14, 2023

First Posted (Actual)

July 18, 2023

Study Record Updates

Last Update Posted (Actual)

July 18, 2023

Last Update Submitted That Met QC Criteria

July 14, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Low shrinkage giomer

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caries Class II

Clinical Trials on Beautifil II LS (Low-Shrinkage)

Subscribe